Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Menichetti

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Open Forum Infectious Diseases|June 30, 2021
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 <i>Klebsiella pneumoniae</i>-Producing KPC-31, a D179Y Variant of KPC-3Giusy Tiseo, Marco Falcone, Alessandro Leonildi, et al.
The New Microbiologica|May 18, 2017
Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experiencePaola Lambelet, Carlo Tascini, Simona Fortunato, et al.
Expert Review of Anti-Infective Therapy|February 6, 2020
Acute wound infections management: the 'Don'ts' from a multidisciplinary expert panelGabriele Sganga, Federico Pea, Domenico Aloj, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2022
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumanniiMarco Falcone, Giusy Tiseo, Alessandro Leonildi, et al.
Le Infezioni in Medicina|March 31, 2015
[Histoplasmosis: the multiple sides of an uncommon disease]Francesco Amadori, Roberta Doria, Giulia Gemignani, et al.
BMC Infectious Diseases|January 1, 2015
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational studyClaudio Viscoli, Matteo Bassetti, Elio Castagnola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2012
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unitFrancesco Sbrana, Paolo Malacarne, Bruno Viaggi, et al.
The New Microbiologica|October 20, 2010
Acute varicella-zoster virus necrotizing meningoencephalomyelitis with sudden visual loss and paraparesis in an HIV-infected patientCarlo Tascini, Marina Polidori, Sarah Flammini, et al.
Diabetes Research and Clinical Practice|August 10, 2011
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapyCarlo Tascini, Alberto Piaggesi, Enrico Tagliaferri, et al.
Open Forum Infectious Diseases|May 30, 2024
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the CulpritKamilia Abdelraouf, Christian M Gill, Matthew Gethers, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Open Forum Infectious Diseases|June 30, 2021
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 <i>Klebsiella pneumoniae</i>-Producing KPC-31, a D179Y Variant of KPC-3Giusy Tiseo, Marco Falcone, Alessandro Leonildi, et al.
The New Microbiologica|May 18, 2017
Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experiencePaola Lambelet, Carlo Tascini, Simona Fortunato, et al.
Expert Review of Anti-Infective Therapy|February 6, 2020
Acute wound infections management: the 'Don'ts' from a multidisciplinary expert panelGabriele Sganga, Federico Pea, Domenico Aloj, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2022
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumanniiMarco Falcone, Giusy Tiseo, Alessandro Leonildi, et al.
Le Infezioni in Medicina|March 31, 2015
[Histoplasmosis: the multiple sides of an uncommon disease]Francesco Amadori, Roberta Doria, Giulia Gemignani, et al.
BMC Infectious Diseases|January 1, 2015
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational studyClaudio Viscoli, Matteo Bassetti, Elio Castagnola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2012
Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unitFrancesco Sbrana, Paolo Malacarne, Bruno Viaggi, et al.
The New Microbiologica|October 20, 2010
Acute varicella-zoster virus necrotizing meningoencephalomyelitis with sudden visual loss and paraparesis in an HIV-infected patientCarlo Tascini, Marina Polidori, Sarah Flammini, et al.
Diabetes Research and Clinical Practice|August 10, 2011
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapyCarlo Tascini, Alberto Piaggesi, Enrico Tagliaferri, et al.
Open Forum Infectious Diseases|May 30, 2024
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the CulpritKamilia Abdelraouf, Christian M Gill, Matthew Gethers, et al.
Pageof 15